Annie Albert Demin
AstraZeneca (United Kingdom)(GB)
Publications by Year
Research Areas
DNA Repair Mechanisms, PARP inhibition in cancer therapy, Genomics and Chromatin Dynamics, CRISPR and Genetic Engineering, Bacterial Genetics and Biotechnology
Most-Cited Works
- → The Importance of Poly(ADP-Ribose) Polymerase as a Sensor of Unligated Okazaki Fragments during DNA Replication(2018)394 cited
- → XRCC1 prevents toxic PARP1 trapping during DNA base excision repair(2021)189 cited
- → XRCC1 protects transcription from toxic PARP1 activity during DNA base excision repair(2021)67 cited
- → Rad52/Rad59-dependent Recombination as a Means to Rectify Faulty Okazaki Fragment Processing(2014)21 cited
- → GSK-3β Homolog Rim11 and the Histone Deacetylase Complex Ume6-Sin3-Rpd3 Are Involved in Replication Stress Response Caused by Defects in Dna2(2017)4 cited
- → The secondary‐structured DNA‐binding activity of Dna2 endonuclease/helicase is critical to cell growth under replication stress(2020)3 cited
- → Abstract B058: Combination of the PARP1-selective inhibitor AZD5305 with the ATR inhibitor ceralasertib for the treatment of PARPi-resistant cancer(2023)1 cited
- Rim11, the Human GSK-3β Homolog Is Involved in Replication Stress Response in Yeasts(2016)
- Rim11, the human GSK-3$\beta$ homolog is involved in replication stress response in yeasts = 인간GSK-3$\beta$에 해당하는 효모 Rim11이 DNA복제 스트레스에 갖는 기능연구(2015)